HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXdChristian F. Singer, Stephan Jahn, Dominik Hlauschek et al.|癌症：英文版|2025Cited by 3